- Home
- PCLA vs BCTX Comparison
PCLA vs BCTX Comparison
Compare PCLA & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCLA
- BCTX
- Stock Information
- Founded
- PCLA 2008
- BCTX 2014
- Country
- PCLA Japan
- BCTX Canada
- Employees
- PCLA N/A
- BCTX N/A
- Industry
- PCLA Building Products
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- PCLA Consumer Discretionary
- BCTX Health Care
- Exchange
- PCLA Nasdaq
- BCTX Nasdaq
- Market Cap
- PCLA 14.2M
- BCTX 14.4M
- IPO Year
- PCLA 2025
- BCTX N/A
- Fundamental
- Price
- PCLA $0.45
- BCTX $7.72
- Analyst Decision
- PCLA
- BCTX Strong Buy
- Analyst Count
- PCLA 0
- BCTX 1
- Target Price
- PCLA N/A
- BCTX $40.00
- AVG Volume (30 Days)
- PCLA 203.2K
- BCTX 92.9K
- Earning Date
- PCLA 01-01-0001
- BCTX 10-28-2025
- Dividend Yield
- PCLA N/A
- BCTX N/A
- EPS Growth
- PCLA N/A
- BCTX N/A
- EPS
- PCLA N/A
- BCTX N/A
- Revenue
- PCLA $5,475,228.00
- BCTX N/A
- Revenue This Year
- PCLA N/A
- BCTX N/A
- Revenue Next Year
- PCLA N/A
- BCTX N/A
- P/E Ratio
- PCLA N/A
- BCTX N/A
- Revenue Growth
- PCLA 40.19
- BCTX N/A
- 52 Week Low
- PCLA $0.37
- BCTX $6.00
- 52 Week High
- PCLA $9.80
- BCTX $294.00
- Technical
- Relative Strength Index (RSI)
- PCLA 39.50
- BCTX 40.75
- Support Level
- PCLA $0.43
- BCTX $7.28
- Resistance Level
- PCLA $0.53
- BCTX $8.82
- Average True Range (ATR)
- PCLA 0.05
- BCTX 0.74
- MACD
- PCLA 0.03
- BCTX 0.58
- Stochastic Oscillator
- PCLA 15.73
- BCTX 60.82
About PCLA PicoCELA Inc. American Depositary Shares
PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.